Navigation Links
Nano-tech makes medicine greener

Over the last 5 years the Bionano Group at the Nano-Science Center and the Department of Neuroscience and Pharmacology at the University of Copenhagen has been working hard to characterise and test how molecules react, combine together and form larger molecules, which can be used in the development of new medicine.

The researchers' breakthrough, as published in the prestigious journal Nature Nanotechnology, is that they are able to work with reactions that take place in very small volumes, namely 10-19 liters. This is a billion times smaller than anyone has managed to work with before. Even more intriguing is the ability to do so in parallel for millions of samples on a single chip.

"We are the first in the world to demonstrate that it is possible to mix and work with such small amounts of material. When we reach such unprecedented small volumes we can test many more reactions in parallel and that is the basis for the development of new drugs. In addition, we have reduced our use of materials considerably and that is beneficial to both the environment and the pocketbook," says professor Dimitrios Stamou, who predicts that the method will be of interest to industry because it makes it possible to investigate drugs faster, cheaper and greener.

The team of professor Stamou reached such small scales because they are working with self-assembling systems. Self-assembling systems, such as molecules, are biological systems that organise themselves without outside control.

This occurs because some molecules fit with certain other molecules so well that they assemble together into a common structure. Self-assembly is a fundamental principle in nature and occurs at all the different size scales, ranging from the formation of solar systems to the folding of DNA.

"By using nanotechnology we have been able to observe how specific self-assembling systems, such as biomolecules, react to different substances and have used this knowledge to develop the method. The self-assembling systems consist entirely of biological materials such as fat and as a result do not impact the environment, in contrast to the materials commonly used in industry today (e.g. plastics, silicon and metals). This and the dramatic reduction in the amount of used materials makes the technique more environment friendly, 'greener'," explains Dimitrios Stamou, who is part of the Synthetic Biology Center and director of the Lundbeck Center Biomembranes in Nanomedicine.


Contact: Dimitrios Stamou
University of Copenhagen

Related biology news :

1. Trustee makes donation to start new solar energy research center at Rensselaer
2. What makes an axon an axon?
3. Feed a cold, feed a fever: Research shows calorie cut makes it harder to fight flu
4. Fly guy makes memory breakthrough
5. Our unconscious brain makes the best decisions possible
6. Biophysical Reviews makes debut in 2009
7. Tree lizard’s quick release escape system makes jumpers turn somersaults
8. Rett Syndrome Research Trust advisor makes significant discovery
9. Peptides-on-demand: McGill researchers radical new green chemistry makes the impossible possible
10. Mount Sinai Hospital researcher makes stem cell breakthrough
11. Red wine vs. white? It makes no difference when it comes to breast-cancer risk
Post Your Comments:
(Date:11/18/2015)... 18, 2015 --> ... new market report titled  Gesture Recognition Market - Global ... - 2021. According to the report, the global gesture recognition market was ... to reach US$29.1 bn by 2021, at a CAGR ... North America dominated the global gesture recognition ...
(Date:11/16/2015)... Calif. , Nov 16, 2015  Synaptics ... of human interface solutions, today announced expansion of ... TouchView ™ touch controller and display driver ... revolution of smartphones. These new TDDI products add ... TD4100 (HD resolution), TD4302 (WQHD resolution), and TD4322 ...
(Date:11/10/2015)... 10, 2015  In this report, the ... of product, type, application, disease indication, and ... report are consumables, services, software. The type ... biomarkers, efficacy biomarkers, and validation biomarkers. The ... diagnostics development, drug discovery and development, personalized ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... and NEW YORK , November 24, ... investment by Bristol-Myers Squibb in a European ... Bristol-Myers Squibb Company in which the companies will work ... immuno-oncology and other areas of unmet medical need. The collaboration ... LSP 5, the latest LSP fund. This is the first ...
(Date:11/24/2015)... , Nov. 24, 2015 According to two new ... 2005. This is something that many doctors, scientists, and public ... questions remains: with fewer PSA tests being done, will there ... Dr. David Samadi, "Despite the efforts made ... remains the second leading cancer cause of death in men, ...
(Date:11/23/2015)... Nov. 23, 2015   Ceres, Inc . (Nasdaq: ... financial results for the fiscal year ended August 31, ... --> --> During fiscal ... and feed products with a better balance of yield, ... distribution agreements with several leading crop input providers and ...
(Date:11/23/2015)... Md. (PRWEB) , ... November 23, 2015 , ... ... 100 award for the development of its Nexera UC Unified Chromatography system. The ... 100 most technically significant new products of the year in the analytical and ...
Breaking Biology Technology: